Vivani Medical, Inc. Common Stock (DE) VANI
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-12T02:01:11.700Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T23:16:17.38138798Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-12T02:01:11.275811+00:00
Vivani Medical, Inc. Common Stock (DE) options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | 1.47 | 197.7% | 40.5% | |||
| 50Δ | 1.39 | 185.4% | 34.1% | |||
| 55Δ | 1.31 | 173.1% | 27.7% | |||
| 60Δ | 1.22 | 160.8% | 21.2% | |||
| 65Δ | 1.14 | 148.5% | 14.8% | |||
| 70Δ | 1.06 | 136.3% | 8.3% | 4.38 | 779.1% | 54.6% |
| 75Δ | 4.85 | 753.1% | 20.5% | |||
| 80Δ | ||||||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 1.47
- IV
- 197.7%
- B/E move
- 40.5%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 1.39
- IV
- 185.4%
- B/E move
- 34.1%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 1.31
- IV
- 173.1%
- B/E move
- 27.7%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 1.22
- IV
- 160.8%
- B/E move
- 21.2%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 1.14
- IV
- 148.5%
- B/E move
- 14.8%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 1.06
- IV
- 136.3%
- B/E move
- 8.3%
- Pseudo strike
- 4.38
- IV
- 779.1%
- B/E move
- 54.6%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.85
- IV
- 753.1%
- B/E move
- 20.5%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
No recorded observations
Biotechnology
VCEL
Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cell therapies for the sports medicine and severe burn care…
More →VERA
Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases in the United…
More →VERU
Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. The company is headquartered in Miami, Florida.
More →VIR
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San…
More →VKTX
Description unavailable
More →VNDA
Description unavailable
More →